These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6120408)

  • 1. Verapamil in Duchenne muscular dystrophy.
    Emery AE; Skinner R; Howden LC; Matthews MB
    Lancet; 1982 Mar; 1(8271):559. PubMed ID: 6120408
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol ineffective in Duchenne muscular dystrophy.
    Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
    Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
    [No Abstract]   [Full Text] [Related]  

  • 3. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
    Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
    Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
    [No Abstract]   [Full Text] [Related]  

  • 4. Mazindol and growth hormone inhibition in Duchenne muscular dystrophy.
    Zatz M; Vainzof M; Rapaport D; da Rocha JM; Pavanello Rde C; Betti RT
    Am J Med Genet; 1987 Aug; 27(4):993-5. PubMed ID: 3321999
    [No Abstract]   [Full Text] [Related]  

  • 5. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
    Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
    Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of vasoactive and antiserotonin drugs in Duchenne muscular dystrophy.
    Patten BM; Zeller RS
    Ann Clin Res; 1983 Aug; 15(4):164-6. PubMed ID: 6360027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.
    Stern LM; Fewings JD; Bretag AH; Ballard FJ; Tomas FM; Cooper DM; Goldblatt E
    Neurology; 1981 Apr; 31(4):422-6. PubMed ID: 7012668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
    Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
    Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
    Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
    Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol.
    Cornelio F; Dworzak F; Morandi L; Fedrizzi E; Balestrini MR; Gondoni L
    Ital J Neurol Sci; 1982 Dec; 3(4):323-30. PubMed ID: 6762370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
    Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
    Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trial of isaxonine in Duchenne muscular dystrophy.
    Heckmatt JZ; Hyde SA; Gabain A; Dubowitz V
    Muscle Nerve; 1988 Aug; 11(8):836-47. PubMed ID: 3050510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of corticosteroid in the treatment of Duchenne (pseudo-hypertrophic) muscular dystrophy. Report of a clinically matched three year double-blind study.
    Siegel IM; Miller JE; Ray RD
    IMJ Ill Med J; 1974 Jan; 145(1):32-3 passim. PubMed ID: 4149478
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of benefit of allopurinol in Duchenne dystrophy.
    Mendell JR; Wiechers DO
    Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
    Mendell JR; Griggs RC; Moxley RT; Fenichel GM; Brooke MH; Miller JP; Province MA; Dodson WE
    Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Prednisone in Duchenne muscular dystrophy.
    Munsat TL; Walton JN
    Lancet; 1975 Feb; 1(7901):276-7. PubMed ID: 46418
    [No Abstract]   [Full Text] [Related]  

  • 18. Mazindol in Duchenne muscular dystrophy.
    Coakley JH; Edwards RH; Moorcraft J; Hipkin LJ; Smith CS
    Lancet; 1988 Jan; 1(8578):184. PubMed ID: 2893022
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy].
    Steru D; Paclet JP; Barthelet G; Gailliard G; Piton A; Monchartre E; Roche R; Galli J; Lancrenon S; Fermanian J
    Arch Fr Pediatr; 1987; 44(6):461-5. PubMed ID: 3619586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.